![](/img/cover-not-exists.png)
Multicenter Phase 2 Trial of Gemcitabine, Carboplatin, and Sorafenib in Patients With Metastatic or Unresectable Transitional-Cell Carcinoma
Hurwitz, Michael E., Markowski, Paul, Yao, Xiaopan, Deshpande, Hari, Patel, Jaymin, Mortazavi, Amir, Donadio, Alessia, Stein, Mark N., Kelly, William Kevin, Petrylak, Daniel Peter, Mehnert, Janice M.Language:
english
Journal:
Clinical Genitourinary Cancer
DOI:
10.1016/j.clgc.2018.07.021
Date:
July, 2018
File:
PDF, 637 KB
english, 2018